PL1835923T3 - Schematy wiskosuplementacji dostawowej - Google Patents

Schematy wiskosuplementacji dostawowej

Info

Publication number
PL1835923T3
PL1835923T3 PL05855034T PL05855034T PL1835923T3 PL 1835923 T3 PL1835923 T3 PL 1835923T3 PL 05855034 T PL05855034 T PL 05855034T PL 05855034 T PL05855034 T PL 05855034T PL 1835923 T3 PL1835923 T3 PL 1835923T3
Authority
PL
Poland
Prior art keywords
regimens
intra
articular viscosupplementation
viscosupplementation
articular
Prior art date
Application number
PL05855034T
Other languages
English (en)
Inventor
Francois Bailleul
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36633154&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1835923(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of PL1835923T3 publication Critical patent/PL1835923T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
PL05855034T 2004-12-30 2005-12-20 Schematy wiskosuplementacji dostawowej PL1835923T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64074904P 2004-12-30 2004-12-30
EP05855034.4A EP1835923B1 (en) 2004-12-30 2005-12-20 Regimens for intra-articular viscosupplementation
PCT/US2005/046409 WO2006073835A2 (en) 2004-12-30 2005-12-20 Regiments for intra-articular viscosupplementation

Publications (1)

Publication Number Publication Date
PL1835923T3 true PL1835923T3 (pl) 2014-03-31

Family

ID=36633154

Family Applications (2)

Application Number Title Priority Date Filing Date
PL05855034T PL1835923T3 (pl) 2004-12-30 2005-12-20 Schematy wiskosuplementacji dostawowej
PL13180465T PL2664334T3 (pl) 2004-12-30 2005-12-20 Schematy wiskosuplementacji dostawowej

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13180465T PL2664334T3 (pl) 2004-12-30 2005-12-20 Schematy wiskosuplementacji dostawowej

Country Status (16)

Country Link
US (4) US7931030B2 (pl)
EP (5) EP2664334B1 (pl)
JP (4) JP5725594B2 (pl)
KR (3) KR101808800B1 (pl)
CN (4) CN101094680A (pl)
AU (1) AU2005323095B2 (pl)
BR (1) BRPI0518542A2 (pl)
CA (2) CA2590159C (pl)
DK (2) DK1835923T3 (pl)
ES (2) ES2537751T3 (pl)
HU (1) HUE025255T2 (pl)
IL (1) IL183581A (pl)
PL (2) PL1835923T3 (pl)
PT (2) PT2664334E (pl)
SI (2) SI1835923T1 (pl)
WO (1) WO2006073835A2 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
EP2664334B1 (en) 2004-12-30 2015-03-04 Genzyme Corporation Regimens for intra-articular viscosupplementation
CA2633957A1 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
CA2633978A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
CA2633954A1 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
EP2386306A1 (en) * 2006-12-06 2011-11-16 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
JP5722217B2 (ja) 2008-09-02 2015-05-20 アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎ Ｈｏｌｄｉｎｇｓ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． ヒアルロン酸および／またはその誘導体の糸、その作製方法、ならびにその使用
MX2012000521A (es) * 2009-07-10 2012-07-17 Milux Holding Sa Dispositivo medico implantable para la lubricacion de una articulacion sinovial y metodo para implantar el dispositivo.
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
EP2609924A4 (en) 2010-08-23 2014-01-22 Denki Kagaku Kogyo Kk NETWORKED HYALURONIC ACID COMPOSITION AND SELF-NETWORKING HYALURONIC ACID PARTICLES
US8613938B2 (en) 2010-11-15 2013-12-24 Zimmer Orthobiologics, Inc. Bone void fillers
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9492474B2 (en) * 2013-07-10 2016-11-15 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
KR101582380B1 (ko) * 2013-09-11 2016-01-05 주식회사 제네웰 손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
WO2015142781A1 (en) * 2014-03-21 2015-09-24 Rmg, Inc. Mobile based exercise and rehabilitation
GB201408752D0 (en) * 2014-05-16 2014-07-02 Stemmatters Biotecnologia E Medicina Regenerativa Sa Arthritis treatment
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
WO2016034745A2 (en) * 2015-09-22 2016-03-10 Cylenchar Limited A method for concentrating and/or entrapping radioisotopes from an aqueous solution
PL3352766T3 (pl) 2015-09-24 2021-08-02 Matrix Biology Institute Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
CN111868528A (zh) 2018-04-03 2020-10-30 赛诺菲 侧向流动免疫测定条状装置
WO2022051060A1 (en) * 2020-09-01 2022-03-10 Orthogenrx, Inc. Crosslinking of non-animal-derived hyaluronic acid with divinyl sulfone

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4636524A (en) * 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US5099013A (en) 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US5246698A (en) 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5143724A (en) 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2061566C (en) * 1992-02-20 2002-07-09 Rudolf E. Falk Treatment of disease employing hyaluronic acid and nsaids
US5219360A (en) * 1991-05-10 1993-06-15 Fortis Research Corporation Mammary prosthesis fill and method of making same
US5143351A (en) * 1991-08-29 1992-09-01 Pierce Daniel H Self-locking valve spring retainer
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
JP3439481B2 (ja) 1995-11-15 2003-08-25 生化学工業株式会社 光架橋ヒアルロン酸ゲルおよびその製造法
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
CZ299025B6 (cs) * 1996-02-09 2008-04-02 Amgen Inc. Farmaceutická kompozice a její použití
JP3521378B2 (ja) * 1996-08-13 2004-04-19 コニカミノルタホールディングス株式会社 両面複写装置
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
PT939086E (pt) * 1998-02-27 2004-07-30 Stichting Hippomedics Processo para produzir o acido hialuronico reticulado
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
KR20010089882A (ko) 1998-11-10 2001-10-12 야노 쓰네오 히알루론산 겔과 그 제조방법 및 이를 함유하는 의료용 재료
US6677321B1 (en) * 1999-12-09 2004-01-13 Bruce Levin Methods and compositions for treatment of inflammatory disease
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US6527760B1 (en) * 2000-09-25 2003-03-04 Vijay B. Vad Out-patient joint lavage kit and protocol
DE60117502T2 (de) 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material
US7119062B1 (en) * 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20030008817A1 (en) * 2001-07-03 2003-01-09 Tom Sander Cross-link reversing agent
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
WO2003074048A1 (en) * 2002-03-01 2003-09-12 Warner-Lambert Company Llc Method of treating osteoarthritis
US20030232784A1 (en) * 2002-06-14 2003-12-18 Benedict James J. Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
JP4383035B2 (ja) * 2002-10-29 2009-12-16 電気化学工業株式会社 ヒアルロン酸ゲル及びその製造方法
DK2163643T3 (en) * 2003-03-05 2015-03-23 Halozyme Inc Soluble hyaluronidaseglycoprotein (sHASEGP), process for preparing the same, pharmaceutical compositions and uses thereof covered
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
AU2004277290B2 (en) * 2003-10-09 2010-05-13 Robert John Petrella Methods for treating acute and overuse sprain and strain using hyaluronic acid
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
AU2004312532B2 (en) 2003-12-30 2010-05-20 Genzyme Corporation Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use
US20080287369A1 (en) * 2004-07-23 2008-11-20 Jay Gregory D Compositions and Methods for Viscosupplementation
WO2006020994A2 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
EP2664334B1 (en) 2004-12-30 2015-03-04 Genzyme Corporation Regimens for intra-articular viscosupplementation
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

Also Published As

Publication number Publication date
KR20070104579A (ko) 2007-10-26
CN102416020A (zh) 2012-04-18
EP2289523A3 (en) 2011-09-28
JP6139716B2 (ja) 2017-05-31
KR101808800B1 (ko) 2018-01-18
PT1835923E (pt) 2013-11-04
CA2744999A1 (en) 2006-07-13
CA2590159C (en) 2011-07-12
WO2006073835A2 (en) 2006-07-13
CN103860582A (zh) 2014-06-18
US20120258931A1 (en) 2012-10-11
EP2664335A2 (en) 2013-11-20
AU2005323095A1 (en) 2006-07-13
EP2664336A3 (en) 2015-12-16
JP2008526747A (ja) 2008-07-24
JP2016128469A (ja) 2016-07-14
EP2289523A2 (en) 2011-03-02
EP1835923B1 (en) 2013-10-09
EP2664334B1 (en) 2015-03-04
CN104689460B (zh) 2018-03-13
US20130197444A1 (en) 2013-08-01
JP2013035860A (ja) 2013-02-21
JP5725594B2 (ja) 2015-05-27
US7931030B2 (en) 2011-04-26
JP2015007077A (ja) 2015-01-15
SI1835923T1 (sl) 2014-01-31
US20060148755A1 (en) 2006-07-06
US20110183936A1 (en) 2011-07-28
SI2664334T1 (sl) 2015-06-30
BRPI0518542A2 (pt) 2008-11-25
EP1835923A2 (en) 2007-09-26
KR20140041926A (ko) 2014-04-04
EP2664336A2 (en) 2013-11-20
HUE025255T2 (en) 2016-03-29
DK1835923T3 (da) 2013-10-21
WO2006073835A3 (en) 2006-10-05
KR20150052326A (ko) 2015-05-13
IL183581A (en) 2016-10-31
EP2664335A3 (en) 2015-12-16
CN101094680A (zh) 2007-12-26
PL2664334T3 (pl) 2015-08-31
IL183581A0 (en) 2007-10-31
EP2664334A1 (en) 2013-11-20
ES2436179T3 (es) 2013-12-27
PT2664334E (pt) 2015-04-23
CA2590159A1 (en) 2006-07-13
CN104689460A (zh) 2015-06-10
DK2664334T3 (en) 2015-03-23
ES2537751T3 (es) 2015-06-11
AU2005323095B2 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
SI1835923T1 (sl) ReĹľimi za intraartikularno viskosuplementacijo
EP1773933A4 (en) FUEL SUPPLY OF FUEL CELLS
ZA200709985B (en) Transesterification methods
ZA200608448B (en) Methods for interfering with fibrosis
GB0413747D0 (en) Optical keyboard
EP1946215A4 (en) COMPUTER MODE "DIRECT EXPERIENCE"
IL179009A0 (en) Purine derivative
PL2816118T3 (pl) Sposoby dostarczania genów
GB2431619B (en) Keyboard for minimizing non-productive hand movements
SG119251A1 (en) Methods
AU305435S (en) Planer
HU0400305D0 (en) Set for spine-fixture
GB0524237D0 (en) Fuel system -9
GB0403629D0 (en) Methods
GB0423552D0 (en) Methods
GB2420279B (en) Environmentally controlled unit
AU156895S (en) Planer
IL184372A0 (en) Method for delivering interferon-??
GB0401020D0 (en) Time panels
GB0415757D0 (en) Methods
HU0400020V0 (en) Case for cigarette-packet
GB0422950D0 (en) Fairing
HK1062788A2 (en) An improved structure for torch
GB0515300D0 (en) Time synchronisation
PL366681A1 (pl) Zespół prądotwórczy